iRhythm Holdings (IRTC) EBIT Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn | 50.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.29% |
| Dec 31, 2025 | 155.99% |
| Sep 30, 2025 | 83.24% |
| Jun 30, 2025 | 18.59% |
| Mar 31, 2025 | 14.64% |
| Dec 31, 2024 | 89.58% |
| Sep 30, 2024 | -82.24% |
| Jun 30, 2024 | -21.77% |
| Mar 31, 2024 | 3.46% |
| Dec 31, 2023 | -89.30% |
| Sep 30, 2023 | -30.91% |
| Jun 30, 2023 | 19.53% |
| Mar 31, 2023 | 18.63% |
| Dec 31, 2022 | 35.72% |
| Sep 30, 2022 | 9.43% |
| Jun 30, 2022 | -38.01% |
| Mar 31, 2022 | -76.73% |
| Dec 31, 2021 | -236.07% |
| Sep 30, 2021 | -389.43% |
| Jun 30, 2021 | 15.72% |
| Mar 31, 2021 | -199.47% |
| Dec 31, 2020 | 45.95% |
| Sep 30, 2020 | 73.95% |
| Jun 30, 2020 | -90.84% |
| Mar 31, 2020 | -11.81% |
| Dec 31, 2019 | -35.41% |
| Sep 30, 2019 | -98.03% |
| Jun 30, 2019 | 17.34% |
| Mar 31, 2019 | 22.59% |
| Dec 31, 2018 | -19.64% |
| Sep 30, 2018 | -54.12% |
| Jun 30, 2018 | -115.86% |
| Mar 31, 2018 | -123.35% |
| Dec 31, 2017 | -151.66% |
| Sep 30, 2017 | -124.42% |
| Jun 30, 2017 | -60.16% |
| Mar 31, 2017 | 2.59% |
| Dec 31, 2016 | 36.93% |
| Sep 30, 2016 | 51.53% |